Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perspective
  • Published:

Redefining a sexual medicine paradigm: subclinical premature ejaculation as a new taxonomic entity

Nature Reviews Urology volume 18, pages 115–127 (2021)Cite this article

Subjects

Abstract

Premature ejaculation (PE) and poor ejaculatory control are multidimensional sexual symptoms estimated to affect almost one-third of men, severely impairing the overall quality of life of patients and their partners. However, patients who do not completely fulfil the definition criteria for PE rarely receive a diagnosis or adequate treatment, with the risk of subsequent progression from initial, subclinical symptoms to clinically overt PE, frequently with other sexual comorbidities. Thus, the current definitions of PE warrant review, in order to consider and propose a new taxonomy encompassing other unaddressed, crucial clinical aspects of PE. These newly proposed criteria include the recommendation for a primary screening for erectile dysfunction (ED), as PE and ED can be comorbid in up to 50% of patients but have never before been considered as a unified clinical entity. In order to facilitate clinical practice and improve clinical management of men with PE and comorbid conditions, we propose and define the new taxonomic clinical entities of subclinical PE (SPE) and loss of control of erection and ejaculation (LCEE). Application of these diagnoses to men who meet the criteria for SPE and/or LCEE, but not the overt conditions, could improve access to treatment for these patients and reduce progression to the more serious clinical disorder.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Evolution of the PE scientific literature.
Fig. 2: Variation in parameters defining PE.
Fig. 3: Measuring a couple’s sexual health.
Fig. 4: Managing ejaculation disorders in clinical practice.
Fig. 5: The cycle of male sexual dysfunctions.

Similar content being viewed by others

References

  1. Jannini, E. A. & Lenzi, A. Ejaculatory disorders: epidemiology and current approaches to definition, classification and subtyping. World J. Urol. 23, 68–75 (2005).

    Article  PubMed  Google Scholar 

  2. Serefoglu, E. C. et al. Prevalence of the complaint of ejaculating prematurely and the four premature ejaculation syndromes: results from the Turkish Society of Andrology Sexual Health Survey. J. Sex. Med. 8, 540–548 (2011).

    Article  PubMed  Google Scholar 

  3. Laumann, E. O., Paik, A. & Rosen, R. C. Sexual dysfunction in the United States: prevalence and predictors. JAMA 281, 537–544 (1999).

    Article  CAS  PubMed  Google Scholar 

  4. Laumann, E. O. et al. Sexual problems among women and men aged 40–80 y: prevalence and correlates identified in the global study of sexual attitudes and behaviors. Int. J. Impot. Res. 17, 39–57 (2005).

    Article  CAS  PubMed  Google Scholar 

  5. Nolazco, C. et al. Prevalence of sexual dysfunctions in Argentina. Int. J. Impot. Res. 16, 69–72 (2004).

    Article  CAS  PubMed  Google Scholar 

  6. Tang, W. S. & Khoo, E. M. Prevalence and correlates of premature ejaculation in a primary care setting: a preliminary cross-sectional study. J. Sex. Med. 8, 2071–2078 (2011).

    Article  PubMed  Google Scholar 

  7. Basile Fasolo, C. et al. Premature ejaculation: prevalence and associated conditions in a sample of 12,558 men attending the andrology prevention week 2001 — a study of the Italian society of andrology (SIA). J. Sex. Med. 2, 376–382 (2005).

    Article  CAS  PubMed  Google Scholar 

  8. Porst, H. et al. The premature ejaculation prevalence and attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur. Urol. 51, 816–823 (2007).

    Article  PubMed  Google Scholar 

  9. Patrick, D. et al. Premature ejaculation: an observational study of men and their partners. J. Sex. Med. 2, 358–367 (2005).

    Article  PubMed  Google Scholar 

  10. Giuliano, F. et al. Premature ejaculation: results from a five-country European observational study. Eur. Urol. 53, 1048–1057 (2008).

    Article  PubMed  Google Scholar 

  11. Montorsi, F. Prevalence of premature ejaculation: a global and regional perspective. J. Sex. Med. 2, 96–102 (2005).

    Article  PubMed  Google Scholar 

  12. Jannini, E. A. et al. Premature ejaculation: old story, new insights. Fertil. Steril. 104, 1061–1073 (2015).

    Article  PubMed  Google Scholar 

  13. Althof, S. E. et al. An update of the International Society of Sexual Medicine’s guidelines for the diagnosis and treatment of premature ejaculation (PE). Sex. Med. 2, 60–90 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  14. Jannini, E. A., Maggi, M. & Lenzi, A. Evaluation of premature ejaculation. J. Sex. Med. 8, 328–334 (2011).

    Article  PubMed  Google Scholar 

  15. Schapiro, B. Premature ejaculation: a review of 1130 cases. J. Urol. 50, 374–379 (1943).

    Article  Google Scholar 

  16. Jannini, E. A., Simonelli, C. & Lenzi, A. Disorders of ejaculation. J. Endocrinol. Invest. 25, 1006–1019 (2002).

    Article  CAS  PubMed  Google Scholar 

  17. Cihan, A. et al. The relationship between premature ejaculation and hyperthyroidism. J. Urol. 181, 1273–1280 (2009).

    Article  PubMed  Google Scholar 

  18. Cahangirov, A. et al. Investigation of the neural target level of hyperthyroidism in premature ejaculation in a rat model of pharmacologically induced ejaculation. J. Sex. Med. 8, 90–96 (2011).

    Article  PubMed  Google Scholar 

  19. Carani, C. et al. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J. Clin. Endocrinol. Metab. 90, 6472–6479 (2005).

    Article  CAS  PubMed  Google Scholar 

  20. McMahon, C. G., Jannini, E. A., Serefoglu, E. C. & Hellstrom, W. J. The pathophysiology of acquired premature ejaculation. Transl. Androl. Urol. 5, 434–449 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  21. Screponi, E. et al. Prevalence of chronic prostatitis in men with premature ejaculation. Urology 58, 198–202 (2001).

    Article  CAS  PubMed  Google Scholar 

  22. Waldinger, M. D. The neurobiological approach to premature ejaculation. J. Urol. 168, 2359–2367 (2002).

    Article  PubMed  Google Scholar 

  23. Colpi, G. M., Fanciullacci, F., Beretta, G., Negri, L. & Zanollo, A. Evoked sacral potentials in subjects with true premature ejaculation. Andrologia 18, 583–586 (1986).

    Article  CAS  PubMed  Google Scholar 

  24. Janssen, P. K., Zwinderman, A. H., Olivier, B. & Waldinger, M. D. Serotonin transporter promoter region (5-HTTLPR) polymorphism is not associated with paroxetine-induced ejaculation delay in dutch men with lifelong premature ejaculation. Korean J. Urol. 55, 129–133 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  25. Salonia, A. et al. Quantitative sensory testing of peripheral thresholds in patients with lifelong premature ejaculation: a case-controlled study. J. Sex. Med. 6, 1755–1762 (2009).

    Article  PubMed  Google Scholar 

  26. Buvat, J. Pathophysiology of premature ejaculation. J. Sex. Med. 8, 316–327 (2011).

    Article  PubMed  Google Scholar 

  27. Jannini, E. A., McCabe, M. P., Salonia, A., Montorsi, F. & Sachs, B. D. Organic vs. psychogenic? The Manichean diagnosis in sexual medicine. J. Sex. Med. 7, 1726–1733 (2010).

    Article  PubMed  Google Scholar 

  28. Rowland, D. L., Patrick, D. L., Rothman, M. & Gagnon, D. D. The psychological burden of premature ejaculation. J. Urol. 177, 1065–1070 (2007).

    Article  PubMed  Google Scholar 

  29. McMahon, C. G. Current and emerging treatments for premature ejaculation. Sex. Med. Rev. 3, 183–202 (2015).

    Article  PubMed  Google Scholar 

  30. Prieto-Castro, R. et al. Opinions, attitudes, and perceptions in relation to erectile dysfunction and premature ejaculation in the undiagnosed spanish male population. Results of the PANDORA project. J. Sex. Med. 17, 1495–1508 (2020).

    Article  CAS  PubMed  Google Scholar 

  31. Wijesinha, S., Piterman, L. & Kirby, C. N. The male reproductive system — An overview of common problems. Aust. Fam. Physician 42, 276–278 (2013).

    PubMed  Google Scholar 

  32. Vik, A. & Brekke, M. Do patients consult their GP for sexual concerns? A cross sectional explorative study. Scand. J. Prim. Health Care 35, 373–378 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  33. Nazareth, I., Boynton, P. & King, M. Problems with sexual function in people attending London general practitioners: cross sectional study. BMJ 327, 423 (2003).

    Article  PubMed  PubMed Central  Google Scholar 

  34. Burgio, G. et al. Evaluation of the mistakes in self-diagnosis of sexual dysfunctions in 11,000 male outpatients: a real-life study in an andrology clinic. J. Clin. Med. 8, 1679 (2019).

    Article  PubMed Central  Google Scholar 

  35. Gross, S. W. A Practical Treatise on Impotence, Sterility and Allied Disorders of the Male Sexual Organs 2nd edn (H. C. Lea’s Son & Co., 1883).

  36. Jannini, E. A. & Lenzi, A. Epidemiology of premature ejaculation. Curr. Opin. Urol. 15, 399–403 (2005).

    Article  PubMed  Google Scholar 

  37. Crow, B. A. Radical Reminism: A Documentary Reader (New York University Press, 2000).

  38. Waldinger, M. D. in Premature Ejaculation. From etiology to diagnosis and treatment Ch. 2 (eds Jannini, E. A., McMahon, C. & Waldinger, M.) 5–24 (Springer-Verlag, 2013)

  39. Jannini, E. A. et al. Who’s afraid of the G-spot? J. Sex. Med. 7, 25–34 (2010).

    Article  PubMed  Google Scholar 

  40. Jannini, E. A. & Porst, H. A practical approach to premature ejaculation. Introduction: the asynchronous couple. J. Sex. Med. 8, 301–303 (2011).

    Article  PubMed  Google Scholar 

  41. Hellstrom, W., Gittelman, M., Althof, S., Ho, K. F. & Kell, S. Dapoxetine HCl for the treatment of premature ejaculation: a phase II, randomized, double-blind, placebo-controlled study. J. Sex. Med. 1, 59–59 (2004).

    Google Scholar 

  42. Hellstrom, W. J. G. et al. 877: Dapoxetine for the treatment of men with premature ejaculation (PE): dose-finding analysis. J. Urol. 173, 238–238 (2005).

    Article  Google Scholar 

  43. McMahon C.G. et al. An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J. Sex. Med. 5, 1590–1606 (2008).

    Article  PubMed  Google Scholar 

  44. Althof S. et al. International Society for Sexual Medicine’s guidelines for the diagnosis and treatment of premature ejaculation. J. Sex. Med. 7, 2947–2969 (2010).

    Article  PubMed  Google Scholar 

  45. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edn (American Psychiatric Association, 2013).

  46. Waldinger, M. D. et al. A multinational population survey of intravaginal ejaculation latency time. J. Sex. Med. 2, 492–497 (2005).

    Article  PubMed  Google Scholar 

  47. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, DSM-IV-TR 4th edn (American Psychiatric Association, 2010).

  48. Sansone, A., Romanelli, F., Jannini, E. A. & Lenzi, A. Hormonal correlations of premature ejaculation. Endocrine 49, 333–338 (2015).

    Article  CAS  PubMed  Google Scholar 

  49. Burri, A. & Graziottin, A. Cross-cultural differences in women’s sexuality and their perception and impact of premature ejaculation. Urology 85, 118–124 (2015).

    Article  PubMed  Google Scholar 

  50. Shaeer, O. & Shaeer, K. The global online sexuality survey (GOSS): ejaculatory function, penile anatomy, and contraceptive usage among Arabic-speaking Internet users in the Middle East. J. Sex. Med. 9, 425–433 (2012).

    Article  PubMed  Google Scholar 

  51. El-Sakka, A. I. in Cultural Differences and the Practice of Sexual Medicine. Trends in Andrology and Sexual Medicine. Ch. 8 (eds Rowland D. & Jannini E. A.) 135–148 (Springer International Publishing, 2020).

  52. Jannini, E. A., Simonelli, C. & Lenzi, A. Sexological approach to ejaculatory dysfunction. Int. J. Androl. 25, 317–323 (2002).

    Article  CAS  PubMed  Google Scholar 

  53. Sansone, A. et al. The sentiment analysis of tweets as a new tool to measure public perception of male erectile and ejaculatory dysfunctions. Sex. Med. 7, 464–471 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  54. Serefoglu, E. C. et al. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine ad hoc committee for the definition of premature ejaculation. Sex. Med. 2, 41–59 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  55. Masters, W. H. & Johnson, V. E. Human sexual inadequacy 1st edn (Little, 1970).

  56. Rowland, D. L., Cooper, S. E. & Schneider, M. Defining premature ejaculation for experimental and clinical investigations. Arch. Sex. Behav. 30, 235–253 (2001).

    Article  CAS  PubMed  Google Scholar 

  57. Bhat, G. S. & Shastry, A. Use of a stopwatch to measure ejaculatory latency may not be accurate among Indian patients. Indian J. Urol. 33, 300–303 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  58. Waldinger, M. D. & Schweitzer, D. H. Method and design of drug treatment research of subjective premature ejaculation in men differs from that of lifelong premature ejaculation in males: proposal for a new objective measure (part 1). Int. J. Impot. Res. 31, 328–333 (2019).

    Article  PubMed  Google Scholar 

  59. Waldinger, M. D. & Schweitzer, D. H. Changing paradigms from a historical DSM-III and DSM-IV view toward an evidence-based definition of premature ejaculation. Part II — proposals for DSM-V and ICD-11. J. Sex. Med. 3, 693–705 (2006).

    Article  PubMed  Google Scholar 

  60. Montague, D. K. et al. AUA guideline on the pharmacologic management of premature ejaculation (reviewed and validity confirmed in 2010). J. Urol. 172, 290–294 (2004).

    Article  PubMed  Google Scholar 

  61. Waldinger, M. D., Hengeveld, M. W., Zwinderman, A. H. & Olivier, B. An empirical operationalization study of DSM-IV diagnostic criteria for premature ejaculation. Int. J. Psychiatry Clin. Pract. 2, 287–293 (1998).

    Article  CAS  PubMed  Google Scholar 

  62. Althof, S. E. & Symonds, T. Patient reported outcomes used in the assessment of premature ejaculation. Urol. Clin. North. Am. 34, 581–589 (2007).

    Article  PubMed  Google Scholar 

  63. Symonds, T. et al. Development and validation of a premature ejaculation diagnostic tool. Eur. Urol. 52, 565–573 (2007).

    Article  PubMed  Google Scholar 

  64. Yuan, Y. M. et al. Sexual function of premature ejaculation patients assayed with Chinese Index of Premature Ejaculation. Asian J. Androl. 6, 121–126 (2004).

    PubMed  Google Scholar 

  65. Althof, S. et al. Development and validation of a new questionnaire to assess sexual satisfaction, control, and distress associated with premature ejaculation. J. Sex. Med. 3, 465–475 (2006).

    Article  PubMed  Google Scholar 

  66. Janssen, P. K. C. & Waldinger, M. D. Men with subjective premature ejaculation have a similar lognormal IELT distribution as men in the general male population and differ mathematically from males with lifelong premature ejaculation after an IELT of 1.5 minutes (Part 2). Int. J. Impot. Res. 31, 341–347 (2019).

    Article  PubMed  Google Scholar 

  67. Barbonetti, A. et al. Erectile dysfunction and premature ejaculation in homosexual and heterosexual men: a systematic review and meta-analysis of comparative studies. J. Sex. Med. 16, 624–632 (2019).

    Article  PubMed  Google Scholar 

  68. Corty, E. W. Perceived ejaculatory latency and pleasure in different outlets. J. Sex. Med. 5, 2694–2702 (2008).

    Article  PubMed  Google Scholar 

  69. Strassberg, D. S., Kelly, M. P., Carroll, C. & Kircher, J. C. The psychophysiological nature of premature ejaculation. Arch. Sex. Behav. 16, 327–336 (1987).

    Article  CAS  PubMed  Google Scholar 

  70. Rowland, D. L., Strassberg, D. S., de Gouveia Brazao, C. A. & Slob, A. K. Ejaculatory latency and control in men with premature ejaculation. J. Psychosom. Res. 48, 69–77 (2000).

    Article  CAS  PubMed  Google Scholar 

  71. Limoncin, E. et al. The Masturbation Erection Index (MEI): validation of a new psychometric tool, derived from the six-item version of the International Index of Erectile Function (IIEF-6) and from the Erection Hardness Score (EHS), for measuring erectile function during masturbation. BJU Int. 123, 530–537 (2019).

    Article  PubMed  Google Scholar 

  72. Waldinger, M. D. Four measures of investigating ejaculatory performance. J. Sex. Med. 4, 520 (2007).

    Article  PubMed  Google Scholar 

  73. World Health Organization. International Statistical Classification of Diseases and Related Health Problems (10th Revision) (World Health Organization, 1994).

  74. Colpi, G. et al. EAU guidelines on ejaculatory dysfunction. Eur. Urol. 46, 555–558 (2004).

    Article  CAS  PubMed  Google Scholar 

  75. Salonia, A. et al. EAU guidelines on male sexual dysfunction: disorders of ejaculation. Presented at the EAU Annual Congress Amsterdam (2020).

  76. Derogatis, L. R. et al. Responses to the proposed DSM-V changes. J. Sex. Med. 7, 1998–2014 (2010).

    Article  PubMed  Google Scholar 

  77. World Health Organization. International Classification of Diseases for Mortality and Morbidity Statistics (11th Revision) (World Health Organization, 2019).

  78. Waldinger, M. D. Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology. Int. J. Impot. Res. 15, 309–313 (2003).

    Article  CAS  PubMed  Google Scholar 

  79. Son, H., Song, S. H., Kim, S. W. & Paick, J. S. Self-reported premature ejaculation prevalence and characteristics in Korean young males: community-based data from an internet survey. J. Androl. 31, 540–546 (2010).

    Article  PubMed  Google Scholar 

  80. Colonnello, E. & Jannini, E. A. in Cultural Differences and the Practice of Sexual Medicine Trends in Andrology and Sexual Medicine Ch. 6 (eds Rowland, D. & Jannini, E. A.) 95–113 (Springer International Publishing, 2020).

  81. Rosen, R. C. & Althof, S. Impact of premature ejaculation: the psychological, quality of life, and sexual relationship consequences. J. Sex. Med. 5, 1296–1307 (2008).

    Article  PubMed  Google Scholar 

  82. Symonds, T., Roblin, D., Hart, K. & Althof, S. How does premature ejaculation impact a man’s life? J. Sex. Marital. Ther. 29, 361–370 (2003).

    Article  CAS  PubMed  Google Scholar 

  83. Riley, A. & Riley, E. Premature ejaculation: presentation and associations. An audit of patients attending a sexual problems clinic. Int. J. Clin. Pract. 59, 1482–1487 (2005).

    Article  CAS  PubMed  Google Scholar 

  84. Graziottin, A. & Althof, S. What does premature ejaculation mean to the man, the woman, and the couple? J. Sex. Med. 8, 304–309 (2011).

    Article  PubMed  Google Scholar 

  85. Byers, E. S. & Grenier, G. Premature or rapid ejaculation: heterosexual couples’ perceptions of men’s ejaculatory behavior. Arch. Sex. Behav. 32, 261–270 (2003).

    Article  PubMed  Google Scholar 

  86. Hobbs, K., Symonds, T., Abraham, L., May, K. & Morris, M. F. Sexual dysfunction in partners of men with premature ejaculation. Int. J. Impot. Res. 20, 512–517 (2008).

    Article  CAS  PubMed  Google Scholar 

  87. Limoncin, E. et al. Premature ejaculation results in female sexual distress: standardization and validation of a new diagnostic tool for sexual distress. J. Urol. 189, 1830–1835 (2013).

    Article  PubMed  Google Scholar 

  88. Bancroft, J., Carnes, L., Janssen, E., Goodrich, D. & Long, J. S. Erectile and ejaculatory problems in gay and heterosexual men. Arch. Sex. Behav. 34, 285–297 (2005).

    Article  PubMed  Google Scholar 

  89. Jern, P. et al. Subjectively measured ejaculation latency time and its association with different sexual activities while controlling for age and relationship length. J. Sex. Med. 6, 2568–2578 (2009).

    Article  PubMed  Google Scholar 

  90. Shindel, A. W., Vittinghoff, E. & Breyer, B. N. Erectile dysfunction and premature ejaculation in men who have sex with men. J. Sex. Med. 9, 576–584 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

  91. Mondaini, N. et al. Dapoxetine treatment in patients with lifelong premature ejaculation: the reasons of a “Waterloo”. Urology 82, 620–624 (2013).

    Article  PubMed  Google Scholar 

  92. Waldinger, M. D. Premature ejaculation: different pathophysiologies and etiologies determine its treatment. J. Sex. Marital. Ther. 34, 1–13 (2008).

    Article  PubMed  Google Scholar 

  93. Parnham, A. & Serefoglu, E. C. Classification and definition of premature ejaculation. Transl. Androl. Urol. 5, 416–423 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  94. Martin-Tuite, P. & Shindel, A. W. Management options for premature ejaculation and delayed ejaculation in men. Sex. Med. Rev. 8, 473–485 (2020).

    Article  PubMed  Google Scholar 

  95. Althof, S. E. Psychosexual therapy for premature ejaculation. Transl. Androl. Urol. 5, 475–481 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  96. Waldinger, M. D., McIntosh, J. & Schweitzer, D. H. A five-nation survey to assess the distribution of the intravaginal ejaculatory latency time among the general male population. J. Sex. Med. 6, 2888–2895 (2009).

    Article  PubMed  Google Scholar 

  97. Sansone, A. et al. Management of premature ejaculation: a clinical guideline from the Italian society of andrology and sexual medicine (SIAMS). J. Endocrinol. Invest. https://doi.org/10.1007/s40618-020-01458-4 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  98. Melnik, T. et al. Psychosocial interventions for premature ejaculation. Cochrane Database Syst. Rev. 8, CD008195 (2011).

    Google Scholar 

  99. Gul, M. & Kaynar, M. Evaluating the content and quality of information about premature ejaculation on the Internet: what are men being exposed to? Andrologia 49, e12612 (2017).

    Article  Google Scholar 

  100. Limoncin, E. et al. The impact of premature ejaculation on the subjective perception of orgasmic intensity: validation and standardisation of the ‘Orgasmometer’. Andrology 4, 921–926 (2016).

    Article  CAS  PubMed  Google Scholar 

  101. Zhang, D. et al. Paroxetine in the treatment of premature ejaculation: a systematic review and meta-analysis. BMC Urol. 19, 2 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Corona, G. et al. Interplay between premature ejaculation and erectile dysfunction: a systematic review and meta-analysis. J. Sex. Med. 12, 2291–2300 (2015).

    Article  PubMed  Google Scholar 

  103. Kamnerdsiri, W. A., Rodriguez Martinez, J. E., Fox, C. & Weiss, P. Clinical correlation between erectile function and ejaculatory function in the Czech male population. PLoS ONE 13, e0199588 (2018).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  104. Jannini, E. A., Lombardo, F. & Lenzi, A. Correlation between ejaculatory and erectile dysfunction. Int. J. Androl. 28, 40–45 (2005).

    Article  PubMed  Google Scholar 

  105. McMahon, C. G. Screening for erectile dysfunction in men with lifelong premature ejaculation — is the sexual health inventory for men (SHIM) reliable? J. Sex. Med. 6, 567–573 (2009).

    Article  PubMed  Google Scholar 

  106. Morales, A., Barada, J. & Wyllie, M. G. A review of the current status of topical treatments for premature ejaculation. BJU Int. 100, 493–501 (2007).

    Article  CAS  PubMed  Google Scholar 

  107. NIH Consensus Development Panel on Impotence. Impotence. JAMA 270, 83–90 (1993).

    Article  Google Scholar 

  108. Peeters, R. P. Subclinical hypothyroidism. N. Engl. J. Med. 376, 2556–2565 (2017).

    Article  PubMed  Google Scholar 

  109. Fernandez-Alvira, J. M. et al. Predicting subclinical atherosclerosis in low-risk individuals: ideal cardiovascular health score and fuster-BEWAT score. J. Am. Coll. Cardiol. 70, 2463–2473 (2017).

    PubMed  Google Scholar 

  110. Keuthen, N. J. et al. A comparison of clinical vs subclinical skin pickers in Israel. Ann. Clin. Psychiatry 28, 98–104 (2016).

    PubMed  Google Scholar 

  111. Jannini, E. A., Lenzi, A., Isidori, A. & Fabbri, A. Subclinical erectile dysfunction: proposal for a novel taxonomic category in sexual medicine. J. Sex. Med. 3, 787–794 (2006).

    Article  PubMed  Google Scholar 

  112. Mulhall, J. P. et al. The 2018 revision to the process of care model for management of erectile dysfunction. J. Sex. Med. 15, 1434–1445 (2018).

    Article  PubMed  Google Scholar 

  113. Mulhall, J. P., Goldstein, I., Bushmakin, A. G., Cappelleri, J. C. & Hvidsten, K. Validation of the erection hardness score. J. Sex. Med. 4, 1626–1634 (2007).

    Article  PubMed  Google Scholar 

  114. Mollaioli, D. et al. Validation of a visual analogue scale to measure the subjective perception of orgasmic intensity in females: the orgasmometer-F. PLoS ONE 13, e0202076 (2018).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  115. Waldinger, M. D. & Olivier, B. Animal models of premature and retarded ejaculation. World J. Urol. 23, 115–118 (2005).

    Article  PubMed  Google Scholar 

  116. Di Sante, S. et al. Epidemiology of delayed ejaculation. Transl. Androl. Urol. 5, 541–548 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  117. Porst, H. & Burri, A. Fortacin spray for the treatment of premature ejaculation. Urologia 84, 1–10 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  118. European Medicines Agency. Fortacin. EMA https://www.ema.europa.eu/en/medicines/human/EPAR/fortacin (2020).

  119. Carson, C. & Wyllie, M. Improved ejaculatory latency, control and sexual satisfaction when PSD502 is applied topically in men with premature ejaculation: results of a phase III, double-blind, placebo-controlled study. J. Sex. Med. 7, 3179–3189 (2010).

    Article  CAS  PubMed  Google Scholar 

  120. Dinsmore, W. W. & Wyllie, M. G. PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study. BJU Int. 103, 940–949 (2009).

    Article  CAS  PubMed  Google Scholar 

  121. Porst, H. et al. Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: integrated analyses of two phase 3 dapoxetine trials. J. Sex. Med. 7, 2231–2242 (2010).

    Article  PubMed  Google Scholar 

  122. Pryor, J. L. et al. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet 368, 929–937 (2006).

    Article  CAS  PubMed  Google Scholar 

  123. Zhao, G. J., Guo, Q., Li, Y. F. & Zhang, Y. G. Efficacy and safety of dapoxetine for premature ejaculation: an updated systematic review and meta-analysis. Sex. Health 16, 301–313 (2019).

    Article  PubMed  Google Scholar 

  124. Reisman, Y. Sexual consequences of post-SSRI syndrome. Sex. Med. Rev. 5, 429–433 (2017).

    Article  PubMed  Google Scholar 

  125. Jannini, E. A., Isidori, A. M., Aversa, A., Lenzi, A. & Althof, S. E. Which is first? The controversial issue of precedence in the treatment of male sexual dysfunctions. J. Sex. Med. 10, 2359–2369 (2013).

    Article  CAS  PubMed  Google Scholar 

  126. Jannini, E. A., McMahon, C., Chen, J., Aversa, A. & Perelman, M. The controversial role of phosphodiesterase type 5 inhibitors in the treatment of premature ejaculation. J. Sex. Med. 8, 2135–2143 (2011).

    Article  PubMed  Google Scholar 

  127. European Medicines Agency. Priligy. EMA https://www.ema.europa.eu/en/medicines/human/referrals/priligy (2012).

  128. Dresser, M. J., Desai, D., Gidwani, S., Seftel, A. D. & Modi, N. B. Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors. Int. J. Impot. Res. 18, 104–110 (2006).

    Article  CAS  PubMed  Google Scholar 

  129. McMahon, C. G. et al. Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study. J. Sex. Med. 10, 2312–2325 (2013).

    Article  CAS  PubMed  Google Scholar 

  130. Abu El-Hamd, M. & Abdelhamed, A. Comparison of the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation: a randomised placebo-controlled clinical trial. Andrologia https://doi.org/10.1111/and.12829 (2018).

    Article  PubMed  Google Scholar 

  131. Tuken, M., Culha, M. G. & Serefoglu, E. C. Efficacy and safety of dapoxetine/sildenafil combination tablets in the treatment of men with premature ejaculation and concomitant erectile dysfunction-DAP-SPEED Study. Int. J. Impot. Res. 31, 92–96 (2019).

    Article  CAS  PubMed  Google Scholar 

  132. McMahon, C. G., McMahon, C. N., Leow, L. J. & Winestock, C. G. Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: a systematic review. BJU Int. 98, 259–272 (2006).

    Article  CAS  PubMed  Google Scholar 

  133. Wang, W. F., Minhas, S. & Ralph, D. J. Phosphodiesterase 5 inhibitors in the treatment of premature ejaculation. Int. J. Androl. 29, 503–509 (2006).

    Article  CAS  PubMed  Google Scholar 

  134. Aversa, A. et al. Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation. Int. J. Impot. Res. 21, 221–227 (2009).

    Article  CAS  PubMed  Google Scholar 

  135. El-Refai, K., Teaima, M. H. & El-Nabarawi, M. A. Dual-purpose vardenafil hydrochloride/dapoxetine hydrochloride orodispersible tablets: in vitro formulation/evaluation, stability study and in vivo comparative pharmacokinetic study in healthy human subjects. Drug Dev. Ind. Pharm. 44, 988–1000 (2018).

    Article  CAS  PubMed  Google Scholar 

  136. Moudi, E. & Kasaeeyan, A. A. Comparison between tadalafil plus paroxetine and paroxetine alone in the treatment of premature ejaculation. Nephrourol. Mon. 8, e32286 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  137. Bai, Y. et al. Selective serotonin reuptake inhibitors plus phosphodiesterase-5 inhibitors for premature ejaculation: a systematic review and meta-analysis. Urology 86, 758–764 (2015).

    Article  PubMed  Google Scholar 

  138. Sun, Y. et al. Efficacy of phosphodiesterase-5 inhibitor in men with premature ejaculation: a new systematic review and meta-analysis. Urology 86, 947–954 (2015).

    Article  PubMed  Google Scholar 

  139. Men, C., Yu, L., Yuan, H. & Cui, Y. Efficacy and safety of phosphodiesterase type 5 inhibitors on primary premature ejaculation in men receiving selective serotonin reuptake inhibitors therapy: a systematic review and meta-analysis. Andrologia 48, 978–985 (2016).

    Article  CAS  PubMed  Google Scholar 

  140. Martyn-St James, M. et al. Phosphodiesterase type 5 inhibitors for premature ejaculation: a systematic review and meta-analysis. Eur. Urol. Focus. 3, 119–129 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  141. Sridharan, K., Sivaramakrishnan, G., Sequeira, R. P. & Al-Khaja, K. A. Pharmacological interventions for premature ejaculation: a mixed-treatment comparison network meta-analysis of randomized clinical trials. Int. J. Impot. Res. 30, 215–223 (2018).

    Article  CAS  PubMed  Google Scholar 

  142. Ciocca, G. et al. Integrating psychotherapy and pharmacotherapy in the treatment of premature ejaculation. Arab. J. Urol. 11, 305–312 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  143. Jannini, E. A. SM = SM: the interface of systems medicine and sexual medicine for facing non-communicable diseases in a gender-dependent manner. Sex. Med. Rev. 5, 349–364 (2017).

    Article  PubMed  Google Scholar 

  144. Jannini, E. A. & Nappi, R. E. Couplepause: a new paradigm in treating sexual dysfunction during menopause and andropause. Sex. Med. Rev. 6, 384–395 (2018).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrinology & Medical Sexology (ENDOSEX), Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy

    Elena Colonnello, Giacomo Ciocca, Erika Limoncin, Andrea Sansone & Emmanuele A. Jannini

  2. Clinical Psychosexology, Department of Dynamic and Clinical Psychology, University of Rome Sapienza, Rome, Italy

    Giacomo Ciocca

Authors
  1. Elena Colonnello
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giacomo Ciocca
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Erika Limoncin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andrea Sansone
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Emmanuele A. Jannini
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors researched data for the article, made a substantial contribution to the discussion of content, and wrote the manuscript. E.A.J. reviewed and edited the manuscript before submission.

Corresponding author

Correspondence to Emmanuele A. Jannini.

Ethics declarations

Competing interests

E.A.J. has been a consultant and/or paid speaker for: Bayer, IBSA, Menarini, Lundbeck, Otsuka, Pfizer and Shionogi. E.L. and G.C. have been paid speakers for Shionogi. E.L. has also been a fellowship recipient from Pfizer. E.C. and A.S. declare no competing interests.

Additional information

Peer review information

Nature Reviews Urology thanks E. C. Serefoglu, D. Rowland and B. Olivier for their contribution to the peer review of this work.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Colonnello, E., Ciocca, G., Limoncin, E. et al. Redefining a sexual medicine paradigm: subclinical premature ejaculation as a new taxonomic entity. Nat Rev Urol 18, 115–127 (2021). https://doi.org/10.1038/s41585-020-00417-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41585-020-00417-1

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing